The association of BRCA1 mutations with triple-negative breast cancer is well-described [24] and in our study 6 out of the 10 deleterious mutations in this subgroup were in BRCA1, Table 2. The gene discussed is BRCA1; the disease is triple-negative breast carcinoma.